Jim Marshall (not a doctor) said ...
In this video Prostate Cancer Research Institute Executive Director Mark Scholz talks about a clinical trial for men who are metastatic and have rising psa on hormone therapy.
The trial is testing whether adding the PARP inhibitor Lynparza (olaparib) to the super-hormone Zytiga (abiraterone) increases its effectiveness.
You can find out about the clinical trial at:
https://clinicaltrials.gov/ct2/show/study/NCT03732820?show_locs=Y#locn
Details there include:
inclusion details (things you need to get into the trial);
exclusion details (what will keep you out of the trial); and
locations.
Australian locations include:
Box Hill, Australia, 3128
Darlinghurst, Australia, 2010
Greenslopes, Australia, 4120
Herston, Australia, 4029
Kingswood, Australia, 2747
Kurralta Park, Australia, 5037
St Albans, Australia, 3021
Waratah, Australia, 2298
As always, ask your doctor if you think this might be for you.
... end Jim